U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C6H12O5
Molecular Weight 164.1567
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-DEOXYGLUCOSE

SMILES

OC[C@@H](O)[C@@H](O)[C@H](O)CC=O

InChI

InChIKey=VRYALKFFQXWPIH-PBXRRBTRSA-N
InChI=1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1

HIDE SMILES / InChI

Molecular Formula C6H12O5
Molecular Weight 164.1567
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including: http://www.wikidoc.org/index.php/2-Deoxy-D-glucose http://www.drugbank.ca/drugs/DB08831

2-deoxyglucose is predominantly used as a diagnostic agent in its radiolabelled form (fluorine-18 is used as the radiolabel). Therapeutically, 2-deoxyglucose is an investigational drug that is being studied as an anticancer and antiviral agent. The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately, cell survival. With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to penetrate cells. As an experimental drug, 2-deoxyglucose was demonstrated to work as an anticonvulsant in temporal lobe epilepsy. In this condition, 2-deoxyglucose represses the expression of certain proteins that are at high levels after a seizure. Although there are several possible therapeutic indications for 2-deoxyglucose, presently there is no approved indication for 2-deoxyglucose as a therapeutic agent.

CNS Activity

Curator's Comment: Known to be CNS penetrant in rat. Human data not available.

Originator

Sources: DOI: 10.1002/cber.19220550122

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
449.2 μM
45 mg/kg single, oral
dose: 45 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
2-DEOXYGLUCOSE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1107.7 μM × h
45 mg/kg single, oral
dose: 45 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
2-DEOXYGLUCOSE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
7.3 h
45 mg/kg single, oral
dose: 45 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
2-DEOXYGLUCOSE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Lasting glycolytic stress governs susceptibility to urethane-induced lung carcinogenesis in vivo and in vitro.
2016-01-05
Cytotoxic effects of mithramycin DIG-MSK can depend on the rise of autophagy.
2015-10
2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways.
2012-12-15
Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
2012-12
Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
2011-10-01
Deletion of the Mint3/Apba3 gene in mice abrogates macrophage functions and increases resistance to lipopolysaccharide-induced septic shock.
2011-09-16
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes.
2011-05
2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
2011-04
Involvement of H-Ras and reactive oxygen species in proinflammatory cytokine-induced matrix metalloproteinase-13 expression in human articular chondrocytes.
2011-03-15
eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
2011-02
p53 Protects lung cancer cells against metabolic stress.
2010-12
The M3-muscarinic acetylcholine receptor stimulates glucose uptake in L6 skeletal muscle cells by a CaMKK-AMPK-dependent mechanism.
2010-07
Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells.
2010-05
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
2010-04
Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats.
2010-03-15
Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: role of mangiferin.
2009-10
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
2009-08-04
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
2008-12-02
Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK.
2008-09-12
Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress.
2008-03
Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats.
2007-10-31
NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance.
2007-10-26
Altered subcellular distribution of the Alzheimer's amyloid precursor protein under stress conditions.
2007-01
Contrasting actions of prolonged mitogen-activated protein kinase activation on cell survival.
2006-06-30
Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein.
2006-03-01
Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
2006-03
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex.
2005-11-25
Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: induction of antiapoptosis, antioxidant, and detoxification genes.
2005-06
Contribution of the PI 3-kinase/Akt survival pathway toward osmotic preconditioning.
2005-01
Impaired gastric secretion and lack of trophic responses to hypergastrinemia in M3 muscarinic receptor knockout mice.
2003-12
Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.
2003-10
Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
2002-11
Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport.
2002-06-28
Effects of antimetabolites to glucose and fatty acids on galanin-1 receptor mRNA levels in the hypothalamic paraventricular and supraoptic nuclei.
1998-12-21
Effect of inhibition of glucose and fat metabolism on galanin-R1 receptor mRNA levels in the rat hypothalamic paraventricular and supraoptic nuclei.
1998-11-16
Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells.
1997-11-30
Nitrogen dioxide-induced expression of a 78 kDa protein in pulmonary artery endothelial cells.
1996
Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors.
1993-03-15
Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion.
1992-06-01
Trafficking of glucose transporters in 3T3-L1 cells. Inhibition of trafficking by phenylarsine oxide implicates a slow dissociation of transporters from trafficking proteins.
1992-02-01
Evidence that erythroid-type glucose transporter intrinsic activity is modulated by cadmium treatment of mouse 3T3-L1 cells.
1991-10-15
Effects of insulin and phospholipase C in control and denervated rat skeletal muscle.
1991-02
Insulin regulation of hexose transport in mouse 3T3-L1 cells expressing the human HepG2 glucose transporter.
1990-11-25
Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.
1990-09
Uptake and binding of radiolabelled phenylarsine oxide in 3T3-L1 adipocytes.
1990-08-01
Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
1990
A further comparison of insulin- and phorbol ester-stimulated glucose transport in adipocytes.
1989-08
Inhibition of cyclic AMP-dependent induction of ornithine aminotransferase by simple carbohydrates in cultured hepatocytes.
1987-12
A preadipocyte clonal line from mouse brown adipose tissue. Short- and long-term responses to insulin and beta-adrenergics.
1987-01
Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes.
1985-03-10
Patents

Patents

Sample Use Guides

The recommended dose of 2DG in combination with weekly docetaxel is 63 mg/kg/day.
Route of Administration: Oral
In Vitro Use Guide
LKB1-null non-small-cell lung carcinoma cell lines showed a significant decrease in cell viability for all doses tested, even at the lowest dose of 2-deoxyglucose (2.5 mmol/L) compared with LKB1-positive cells.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:55:16 GMT 2025
Edited
by admin
on Mon Mar 31 19:55:16 GMT 2025
Record UNII
9G2MP84A8W
Record Status FAILED
Record Version
  • Download
Name Type Language
2-DEOXY-D-GLUCOSE
HSDB   MART.   MI   USP-RS   WHO-DD  
Preferred Name English
2-DEOXYGLUCOSE
Systematic Name English
2-DEOXY-D-GLUCOSE [MI]
Common Name English
2-DEOXY-D-MANNOSE
Common Name English
BA-2758
Code English
2-DG
Common Name English
D-ARABINO-2-DESOXYHEXOSE
Common Name English
NSC-15193
Code English
D-ARABINO-HEXOSE, 2-DEOXY-
Systematic Name English
2-Deoxy-d-glucose [WHO-DD]
Common Name English
BA 2758
Code English
(3R,4S,5R)-3,4,5,6-TETRAHYDROXYHEXANAL
Systematic Name English
(4R,5S,6R)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2,4,5-TRIOL
Systematic Name English
2-DEOXY-D-ARABINO-HEXOSE
Systematic Name English
2-DEOXY-D-GLUCOSE [MART.]
Common Name English
2-DEOXY-D-GLUCOSE [HSDB]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C344
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
Code System Code Type Description
CHEBI
15866
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
RXCUI
1733674
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
EVMPD
SUB62474
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
NSC
15193
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-823-0
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
PUBCHEM
108223
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
CAS
61-58-5
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
ALTERNATIVE
DRUG BANK
DB08831
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
MERCK INDEX
m4175
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY Merck Index
SMS_ID
100000134458
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
FDA UNII
9G2MP84A8W
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
DAILYMED
9G2MP84A8W
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
CHEBI
84755
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
WIKIPEDIA
2-DEOXY-D-GLUCOSE
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
CAS
154-17-6
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
EPA CompTox
DTXSID1037648
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
HSDB
5484
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY
NCI_THESAURUS
C116618
Created by admin on Mon Mar 31 19:55:16 GMT 2025 , Edited by admin on Mon Mar 31 19:55:16 GMT 2025
PRIMARY NCIT
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY